Table 3.
Development Dataset (KPNW) N = 1006 | ||||||
---|---|---|---|---|---|---|
NLP‐only Classification | na | Performance Compared with Gold Standard Chart Review na = 627 | ||||
Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | |||
Event type, irrespective of substance involved | Intentional overdose | 74 | .81 (.70‐.89) | .98 (.96‐.99) | .83 (.72‐.91) | .97 (.96‐.99) |
Unintentional overdose | 158 | .71 (.63‐.78) | .94 (.91‐.96) | .79 (.71‐.85) | .91 (.87‐.93) | |
Overdose of any type | 232 | .80 (.74‐.85) | .93 (.90‐.95) | .87 (.81‐.91) | .89 (.85‐.92) | |
Adverse drug reaction—ADR | 79 | .24 (.15‐.35) | .93 (.90‐.95) | .32 (.21‐.45) | .89 (.87‐.92) | |
Substance involved in overdose or ADR | Heroin | 19 | .84 (.60‐.96) | 1.0 (.99‐1.0) | .80 (.56‐.93) | 1.0 (.99‐1.0) |
Opioid only (excludes heroin) | 98 | .37 (.27‐.47) | .94 (.92‐.95) | .39 (.29‐.50) | .93 (.91‐.95) | |
Polysubstance including opioid (excludes heroin) | 175 | .57 (.49‐.64) | .96 (.94‐.97) | .75 (.67‐.82) | .91 (.89‐.93) | |
Any opioid (excludes heroin, includes polysubstance) | 273 | .72 (.66‐.77) | .96 (.94‐.97) | .88 (.83‐.92) | .90 (.87‐.92) | |
Substance abuse involved in opioid‐related overdose | Prescription med abuse (whether prescribed or not) | 56 | .38 (.25‐.51) | .96 (.94‐.98) | .50 (.34‐.66) | .94 (.92‐.96) |
Substance abuse (including alcohol abuse or presence) | 45 | .62 (.47‐.76) | .97 (.95‐.98) | .58 (.43‐.72) | .97 (.95‐.98) | |
Illicit drug abuse | 84 | .46 (.36‐.58) | .97 (.97‐.98) | .68 (.55‐.80) | .92 (.90‐.94) | |
Any substance abuse | 129 | .67 (.59‐.75) | .96 (.94‐.97) | .81 (.72‐.87) | .92 (.89‐.94) | |
Patient error in opioid‐related overdose or ADR | Patient error | 21 | .33 (.15‐.57) | .98 (.96‐.99) | .33 (.15‐.57) | .98 (.96‐.99) |
Abbreviations: KPNW, Kaiser Permanente Northwest; NLP, natural language processing; NPV, negative predictive value; PPV, positive predictive value.
n is the count as determined by gold standard chart review, includes only events for which EHR source data were available.